Thailand is facing dual challenges of an aging population and insufficient healthcare resources in rural areas. S.S.S. Automotive Industry Co., Ltd., a global leader in ambulances, plans to collaborate with Taiwan’s technology industry to further enhance the functionality and efficiency of its smart ambulances, aiming to improve the quality of healthcare services for the elderly population in Thailand’s remote regions.

With the rapid growth of smart healthcare and digital health in the ASEAN region, EP Plus Group Sdn Bhd, a leading healthcare company in ASEAN with a network of over 4,000 partner clinics, recently visited Taiwan to discuss collaboration opportunities. The focus includes expanding the medical device market, particularly in gastrointestinal and diabetes treatment products, while further exploring the potential of digital health and the medical aesthetics industry.

Pharmaniaga, Malaysia's largest publicly listed pharmaceutical company, operates across the entire pharmaceutical value chain, from R&D and the production of generic and over-the-counter drugs to logistics, distribution, sales, and marketing. Now, Pharmaniaga is officially extending a hand of collaboration to Taiwanese pharmaceutical companies, actively seeking partners to jointly explore opportunities in the ASEAN biopharmaceutical market.

Indonesia's healthcare market holds immense potential, with the market size projected to reach $2.2 billion by 2024. As a leading provider of medical diagnostic equipment in the country, Sugih plays a pivotal role in Indonesia's healthcare industry and is actively driving digital transformation. The company aims to leverage Taiwan's expertise in AI diagnostics, data management, and health platform technologies to accelerate the modernization of Indonesia's healthcare system.

The Philippine government is actively promoting the upgrade of its pharmaceutical industry, announcing the establishment of a dedicated economic zone for the sector. This initiative includes tax incentives and expedited drug testing and registration pathways, lowering barriers for international companies entering the Philippine market. As one of the top two pharmaceutical distributors in the Philippines, Ambica represents over 3,000 products from 50 countries worldwide. This time, their visit to Taiwan focuses on seeking partnerships with Taiwanese pharmaceutical companies, aiming to jointly drive the $4 billion pharmaceutical market collaboration boom.